Ligand Pharmaceuticals (NASDAQ: LGND) announced that its partner, Pfizer, Inc. (NYSE: PFE) has received approval from the European Commission(EC) for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE